Nutromics
PrivateLast Round
Acceleration Round
Sep 2, 2025
Total Funding Raised
$18.13M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nutromics is a healthtech company that develops a wearable diagnostic platform featuring DNA-based sensors and microneedles for continuous, real-time monitoring of molecular biomarkers and therapeutic drugs.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nutromics Comparables
Compare Nutromics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adaptyx Biosciences | 84% | |
| Aptec Health | 79% | |
| KitechDx | 78% | |
Nutromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Acceleration Round | Sep 2, 2025 | ||||
| Grant | Apr 27, 2024 | ||||
| VC Round | Jun 8, 2023 | ||||
| Seed | Sep 8, 2022 | ||||
| Grant | Sep 29, 2021 | ||||
Seed | Aug 27, 2021 |
Key People
Founding team and executive leadership
Nutromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| The Actuator | Pre Seed |
| Dexcom Ventures | Seed |
| Artesian | Pre Seed, Seed |
| VU Venture Partners | Seed |
| Australian Federal Government (Cooperative Research Centres Projects grant) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 43% MoM, reaching 2K.
- Apr 7, 2026
Thomas M. Prescott appointed as chair of the board.
Nutromics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nutromics's valuation, stock price, and market status.